Cynthia Smith Akebia Therapeutics, Inc. (AKBA) insider trading activity

AKBA Quotes by TradingView

Cynthia Smith is of Akebia Therapeutics, Inc.. Currently has a direct ownership of 125,233 shares of AKBA, which is worth approximately $230,428. The most recent transaction as insider was on Jun 06, 2024, when has been sold 30,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K
0% 3M change
31.5% 12M change
Total Value Held $230,428

Cynthia Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2024
BUY
Grant, award, or other acquisition
-
30,000 Added 19.33%
125,233 Common Stock
Jun 06 2023
BUY
Grant, award, or other acquisition
-
30,000 Added 23.96%
95,233 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
13,700 Added 17.36%
65,233 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
13,700 Added 21.0%
51,533 Common Stock

Also insider at

AGIO
AGIOS PHARMACEUTICALS, INC. Healthcare
Director
TARA
Protara Therapeutics, Inc. Healthcare
SPRO
Spero Therapeutics, Inc. Healthcare
DRNA
Dicerna Pharmaceuticals Inc
Director
CS

Cynthia Smith

Cambridge, MA

Track Institutional and Insider Activities on AKBA

Follow Akebia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKBA shares.

Notify only if

Insider Trading

Get notified when an Akebia Therapeutics, Inc. insider buys or sells AKBA shares.

Notify only if

News

Receive news related to Akebia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKBA